The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Oral NRC-2694-A in combination with paclitaxel as therapy for recurrent and/or metastatic head and neck squamous cell carcinoma (R/M-HNSCC) that progressed on or after an immune checkpoint inhibitor (ICI): A multi-center, single-arm, phase 2 trial.
 
Douglas Adkins
Consulting or Advisory Role - Boehringer Ingelheim; Calliditas Therapeutics; CUE Biopharma; Eisai Europe; Exelixis; Genmab/Seattle Genetics; Gilead Sciences; Immunitas; Jazz Pharmaceuticals; Kura Oncology; Merck; Seagen; TargImmune Therapeutics; Vaccinex
Research Funding - Adlai Nortye (Inst); AstraZeneca (Inst); BeiGene (Inst); BioAtla (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Calliditas Therapeutics (Inst); Celgene (Inst); Cofactor Genomics (Inst); CUE Biopharma (Inst); Debiopharm Group (Inst); Epizyme (Inst); Genmab (Inst); Gilead Sciences (Inst); Hookipa Biotech (Inst); Immutep (Inst); ISA Pharmaceuticals (Inst); Kura Oncology (Inst); Lilly (Inst); Merck (Inst); NATCO Pharma (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Tizona Therapeutics, Inc. (Inst); Vaccinex (Inst)
 
Peter John Oppelt
Speakers' Bureau - Bristol Myers Squibb; Eisai; Merck
Research Funding - Enzychem Lifesciences (Inst); HiFiBiO Therapeutics (Inst); Merck (Inst)
 
Jessica C. Ley
No Relationships to Disclose
 
Praveen Chowdary Myneni
Employment - NATCO Pharma
Stock and Other Ownership Interests - NATCO Pharma
Patents, Royalties, Other Intellectual Property - NATCO Pharma
 
Venkata Ramana Gogula
Employment - NATCO Pharma
Stock and Other Ownership Interests - NATCO Pharma
Patents, Royalties, Other Intellectual Property - NATCO Pharma
 
Satish Kanumuri
Employment - NATCO Pharma
 
Sheshubabu Yadla
Employment - NATCO Pharma
Stock and Other Ownership Interests - NATCO Pharma
Patents, Royalties, Other Intellectual Property - NATCO Pharma
 
Venkata Sadu
Employment - NATCO Pharma
Stock and Other Ownership Interests - NATCO Pharma
 
Raghava Kota
Employment - NATCO Pharma
Stock and Other Ownership Interests - NATCO Pharma
 
Saipavan Sanagala
Employment - NATCO Pharma
 
Mounika Surapaneni
Employment - NATCO Pharma